| dc.contributor.author | Grigg, J | |
| dc.date.accessioned | 2021-01-14T12:10:41Z | |
| dc.date.available | 2020-12-01 | |
| dc.date.available | 2021-01-14T12:10:41Z | |
| dc.identifier.issn | 0903-1936 | |
| dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/69715 | |
| dc.description.abstract | The A allele of rs1042713 (Arg16 amino acid) in the β2-adrenoreceptor is associated with poor response to long-acting β2-agonist (LABA) in young people with asthma. Our aim was to assess whether the prescribing of second-line controller with LABA or a leukotriene receptor antagonist according to Arg16Gly genotype would result in improvements in Pediatric Asthma-Related Quality of Life Questionnaire (PAQLQ). | |
| dc.publisher | European Respiratory Society | en_US |
| dc.relation.ispartof | European Respiratory Journal | |
| dc.title | Asthma prescribing according to Arg16Gly beta-2 genotype: a randomized trial in adolescents | en_US |
| dc.type | Article | en_US |
| dc.rights.holder | ©The authors 2021. For reproduction rights and permissions contact permissions@ersnet.org | |
| pubs.notes | Not known | en_US |
| pubs.publication-status | Accepted | en_US |
| dcterms.dateAccepted | 2020-12-01 | |
